within Pharmacolibrary.Drugs.ATC.N;

model N04AA12
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.3,
    Cl             = 0.11666666666666667,
    adminDuration  = 600,
    adminMass      = 0.01,
    adminCount     = 1,
    Vd             = 0.006,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.0008333333333333334,
    Tlag           = 600
  );

  annotation(Documentation(
    info ="<html><body><p>Tropatepine is a central anticholinergic drug used primarily in the management of Parkinson's disease and various parkinsonian syndromes for the treatment of drug-induced extrapyramidal symptoms. Its use today is limited and it is not widely available, having been largely replaced by safer or more effective antiparkinsonian agents.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters for tropatepine have not been determined in published clinical or pharmacokinetic studies. The following parameters are estimated based on values typical for similar anticholinergic drugs.</p><h4>References</h4><ol><li><p>Arnoux, P, et al., &amp; Cano, JP (1986). Simultaneous determination of tropatepine and its major metabolites by high-performance liquid chromatographic-mass spectrometric identification. Application to metabolic and kinetic studies. <i>Journal of chromatography</i> 381(1) 75â€“82. PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/3771726/&quot;>https://pubmed.ncbi.nlm.nih.gov/3771726</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end N04AA12;
